CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID
CB3 is a Ligand Of Interest in 5T0L designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5T0L_CB3_A_703 | 7% | 21% | 0.354 | 0.815 | 1.18 | 2.31 | 3 | 8 | 3 | 0 | 100% | 0.5 |
| 5T0L_CB3_B_703 | 6% | 21% | 0.361 | 0.801 | 1.18 | 2.25 | 3 | 8 | 8 | 0 | 100% | 0.5 |
| 4EIL_CB3_G_702 | 76% | 11% | 0.105 | 0.941 | 1.96 | 2.43 | 8 | 13 | 1 | 0 | 100% | 1 |
| 6AOH_CB3_B_703 | 21% | 19% | 0.297 | 0.91 | 1.18 | 2.4 | 3 | 8 | 1 | 0 | 100% | 0.5 |
| 6AOI_CB3_B_703 | 10% | 20% | 0.362 | 0.869 | 1.16 | 2.39 | 2 | 10 | 1 | 0 | 100% | 0.5 |
| 6AOG_CB3_B_703 | 7% | 21% | 0.4 | 0.854 | 1.15 | 2.32 | 3 | 8 | 3 | 0 | 100% | 0.5 |
| 6NNR_CB3_B_302 | 93% | 21% | 0.076 | 0.97 | 1.19 | 2.25 | 3 | 8 | 0 | 0 | 100% | 1 |
| 4GEV_CB3_B_802 | 87% | 21% | 0.081 | 0.954 | 1.23 | 2.21 | 3 | 8 | 0 | 0 | 100% | 1 |
| 2FTO_CB3_X_266 | 82% | 19% | 0.087 | 0.943 | 1.58 | 2 | 6 | 6 | 1 | 0 | 100% | 1 |
| 6CDZ_CB3_A_701 | 53% | 22% | 0.16 | 0.922 | 1.31 | 2.06 | 3 | 11 | 0 | 0 | 100% | 1 |
| 2OIP_CB3_B_608 | 43% | 4% | 0.208 | 0.934 | 3.17 | 2.93 | 25 | 18 | 1 | 0 | 100% | 1 |
